DNA Corporation (CEO Kyunghwan David Koh) participated in the 'Startup Zone' at the Eureka Park K-STARTUP integrated hall of 'CES 2023' in Las Vegas, USA from January 5 (Thursday) to 8 (Sunday, local time) for a total of 4 days.
DNA Corporation (hereinafter DNA) was founded to take advantage of AI-based DNA data to improve children's lives and the future. With this goal in mind, the startup launched ADHD BANK to facilitate early detection of ADHD and provide personalized diagnosis. The company's vision is to become a leader in shifting the paradigm from traditional diagnostic medicine to futuristic preventive medicine by expanding and adding services going forward.
DNA's ADHD (Attention Deficit Hyperactivity Disorder) genetic test kit ADHD BANK is an AI-based DNA data solution that assists physicians to diagnose and predict ADHD. In 2018, the authoritative journal Nature reported that ADHD shows a high permittivity of 74%, and the compelling genetic characteristics motivated DNA to launch the ADHD BANK service. DNA also obtained a patent on machine learning with a learning algorithm to analyze the latest genetic biomarkers associated with ADHD, which is designed to help ordinary people identify ADHD more easily by rapidly diagnosing ADHD through innovative genomic technology.
According to a representative from DNA, “ADHD is currently being clinically diagnosed by physicians using the DSM-5 criteria and ADHD questionnaire. However, due to the significant shortage of physicians, especially psychiatrists, worldwide, it is difficult for patients with ADHD to receive timely diagnosis and treatment.” They added, “Our innovative technology in combination with clinical approaches is expected to help physicians diagnose difficult cases of ADHD, especially in young children and people with disorders or mental health conditions.”
DNA Corporation (CEO Kyunghwan David Koh) participated in the 'Startup Zone' at the Eureka Park K-STARTUP integrated hall of 'CES 2023' in Las Vegas, USA from January 5 (Thursday) to 8 (Sunday, local time) for a total of 4 days.
DNA Corporation (hereinafter DNA) was founded to take advantage of AI-based DNA data to improve children's lives and the future. With this goal in mind, the startup launched ADHD BANK to facilitate early detection of ADHD and provide personalized diagnosis. The company's vision is to become a leader in shifting the paradigm from traditional diagnostic medicine to futuristic preventive medicine by expanding and adding services going forward.
DNA's ADHD (Attention Deficit Hyperactivity Disorder) genetic test kit ADHD BANK is an AI-based DNA data solution that assists physicians to diagnose and predict ADHD. In 2018, the authoritative journal Nature reported that ADHD shows a high permittivity of 74%, and the compelling genetic characteristics motivated DNA to launch the ADHD BANK service. DNA also obtained a patent on machine learning with a learning algorithm to analyze the latest genetic biomarkers associated with ADHD, which is designed to help ordinary people identify ADHD more easily by rapidly diagnosing ADHD through innovative genomic technology.
According to a representative from DNA, “ADHD is currently being clinically diagnosed by physicians using the DSM-5 criteria and ADHD questionnaire. However, due to the significant shortage of physicians, especially psychiatrists, worldwide, it is difficult for patients with ADHD to receive timely diagnosis and treatment.” They added, “Our innovative technology in combination with clinical approaches is expected to help physicians diagnose difficult cases of ADHD, especially in young children and people with disorders or mental health conditions.”